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SECTION I
INTRODUCTION
INTRODUCTION
Respiratory infections in cattle account for one of the
most serious economic losses in the United States and many
other parts of the world where the livestock industry has gained
high level of economic importance. It is known that the agents
responsible for causing respiratory disease syndrome are mainly
viruses, bacteria and mycoplasma producing different clinical
signs of the disease under varying environmental conditions
(Omar, A. R. , 1966; Rosenquist, B. D. , 1974; Saunders, et al.,
1964) . The interaction of these infectious agents in a host with
a complex immune system makes the clinical syndrome variable and
a definite identification of the pathogens becomes difficult.
A list of all infectious agents involved in the syndrome is
likely to be incomplete as new viral agents are identified from
time to time, but it is generally accepted that the main viral
agents most frequently isolated are bovine virus diarrhea (BVD)
,
infectious bovine rhinotracheitis (IBR) and parainfluenza-3
viruses. Circulating antibodies and/or hemagglutinating titers
to all three viruses have been detected simultaneously in the
same animal (Jensen and Mackay, 1971)
.
Commercial vaccines against both IBR and BVD, consisting of
attenuated viruses grown in tissue cultures have been available,
but are often thought to be responsible for post-vaccinal reactions
(Bittle, 1968; Clark, 1968; McKercher, et al., 1968; Peacock, 1968;
Rcsner, 1968; Peter, et al., 1967; Kelling, et al
.
, 1973; and
Searl (1971) . A strain of BVD virus grown in porcine cells has
been attenuated and used as a vaccine and is not associated with
any adverse reaction in animals (Phillips, et a_l. , 1975). Todd,
et al . (1974) developed an IBRV vaccine for intranasal use that
affords relatively early protection against the disease, however
McKercher, et al . (1971) did not find any added advantages
attributed to intranasal vaccination. Inactivated vaccines have
been available for use against both IBRV (Matsuoka, et al., 1972;
Kolar, et al., 1974; Haralambiev, 1976) and BVDV (Fernelius,
et al. , 1972; McClarkin, et al . , 1975) , but the duration and the
type of immunity conferred by inactivated viral vaccines have
been questioned.
Bovine respiratory disease problems are more frequently
encountered in crowded situations such as in feedlots and during
transportation where the animals are under conditions of stress.
Physiological changes under stress affect the hormonal balance
of the animal and alters the susceptibility of the host to viral
infection (Kilbourne and Horsefall, 1951; Shwartzman, et al.
,
1952; Kass, et al., 1958; Kaufman, 1965; Smart, et al. , 1966;
Reinicke, 1965; Rytel, et al., 1966). Sheffy, et al. (1973)
reported the reappearance of IBRV infection in animals during
times of stress, and recovery of the virus has also been demon-
strated following administration of corticosteroids (Davies,
et al. , 1974) . Both in vitro and in vivo studies revealed that
hormones can change the expression of viral genomes in cells
resulting in increased virus synthesis (Joncas, et al. , 1973;
Hall, et al. , 1977; Jones, et al., 1963). Corticosteroids are
known to be immunosuppressive, lympholytic and cause lesions
on lymphoid tissues (Wallnerova, et al . , 1971) and the administra-
tion of the hormone resulted in potentiation of BVD in calves
(Shope, et al. , 1977).
The objective of this work was to investigate the immune
response in calves vaccinated with modified live and inactivated
vaccines, and to study interaction of viruses and lymphocytes in
the presence of corticosteroids.
SECTION II
REVIEW OF LITERATURE
LITERATURE REVIEW
History of the Viruses . Bovine virus diarrhea was first reported
as a transmissible disease of cattle by Olafson et al. (1946) in
New York; as an X disease of cattle in Canada by Childs in the
same year, and as an epizootic enteritis in Sweden by Hedstrom
et al. (1951) . Ramsey and Chivers (1953) reported a mucosal
disease in the Midwest. Wheat et al. (1954) isolated a virus
diarrhea strain from cattle in California that was immunologi-
cally similar to the New York strain. Since then, the disease
has been reported throughout the United States and many other
countries.
Infectious bovine rhinotracheitis has been recognized as a
disease of cattle since 1950 (Schroeder and Moys, 1954), and
first described as a new respiratory tract disease of cattle in
1955 (Miller, N. J.). Soon it was also associated with infectious
pustulo vulvo vaginitis (IPV) by Kendrick et al. (1958) and
McKercher (1963) . Since the IBR virus also causes IPV, it is
often called IBR-IPV (Baker, et al., 1960; Studdert et al.
,
1964) . Subsequently the disease has been recognized throughout
the United States and has been reported in various parts of the
world.
Epidemiology of the Diseases . Bovine virus diarrhea virus has
been incriminated in a variety of cattle maladies such as respira-
tory illness, diarrhea, abortion and lesions of mucosa of the
gastro-intestinal tract (Kahrs, 1971, Kahrs et al., 1970a,
Gillespie et al. , 1967, Kahrs, 1968 and Kahrs et al . , 1970b).
The prominent signs in a respiratory tract involvement are varied
as recorded in several descriptions of clinical BVD: cough of
different types (Pritchard et al
.
, 1954; Avellini et al., 1968;
Schoop and Wachendorder , 1963; Olafson et al., 1946), increase
in respiratory rate (Ballarini and Ferrari, 1969). Mills (1966)
experimentally infected calves with the Dunkle strain of the BVD
virus and made the following observations: ten days after
inoculation, both in inoculated and in control animals, as a
result of contact and manipulation, there was mild rhinitis.
However, in calves killed after more than ten days post
inoculation, the disparity between infected and control became
marked. In calves killed 25 to 39 days after infection, the
nasal mucosae were reddened and hemorrhagic. Virus was isolated
from the lungs, bronchial lymph nodes, and trachea up to 56 days
after infection by which time it had disappeared from all other
tissues. According to Mills, transmission via the respiratory
route was the probable mode of spread of this disease, but
Pritchard (1963) and Howarth (1972) suggest that the BVD virus
may also be excreted via urine. Apart from being recognized as
a major etiological agent in the respiratory disease syndrome
of cattle, recently BVDV has been shown to be responsible for
abortion in cattle. Since the first report of BVD-MD in cattle,
the virus has been considered an abortifaciant , and abortion
has been described in pregnant cattle in disease outbreaks
(Olafson et al. , 1946). It is known that BVDV is a pathogen
3that can cross the placental barrier of susceptible cattle and
cause infection at any stage of gestation (Kahrs et al_. , 1973;
Casaro et al
.
, 1971; Lambert, G., 1966; Scott et al
.
, 1973).
The disease in calves which develops after an intrauterine infec-
tion depends on the stage of gestation when the fetus is infected.
During the first trimester of pregnancy, if the fetus is infected,
it may die or brain damage may occur resulting in underdevelopment
or hypoplasia of cerebellum. Fetuses that develop an in utero
infection during the second half of gestation may be weak or
scouring (Lambert, 1966). Further, fetal BVD infection has been
substantiated by viral isolation (Casaro, e_t al., 1971; Gillespie,
et al., 1967; Kendrick, 1972, Scott, et al . (1973), and by detec-
tion of serum antibody in fetuses and colostrum-deprived newborn
calves (Casaro, et al., 1971, Classick, et al., 1970, Kendrick,
1971, Kendrick, et al., 1972).
IBRV causes variable clinical symptoms in cattle. Primarily
a respiratory problem, the disease begins with high fever,
depression, anorexia and muco-purulent nasal discharge (Bruner,
et al^.
, 1973, Smith, et al. , 1973). Congested mucous membranes,
shallow ulcers, necrotic areas around the nostrils and muzzle,
conjunctivitis and lacrimation are often seen in the respiratory
form of the disease. Lesions also appear on the pharynx, larynx,
trachea and bronchi (McKercher, 1959), and occasionally, fatal
pneumonia ensues due to asphyxiation by swollen respiratory
mucosae. Abinanti and Plumer (1961) noted that in a natural out-
break of the disease in feedlot cattle, conjunctivitis was the
only evidence of infection, there being no accompanying respira-
tory signs. British workers also described intense conjunctivitis
with lacrimation as the predominant signs in a natural outbreak
(Dawson, et al. , 1962)
.
In addition to causing an upper respiratory disease in cattle,
the virus has been implicated in vulvovaginitis (Gillespie, et al.
,
1957, encephalitis (Barenfus, et al., 1973; Johnston, et al.
,
1962), abortion (Chow, et al., 1964; McKercher, et al., 1964) and
systemic infection in calves (Galloway, 1972) . Abortion in cattle
caused by IBR virus is the result of fetal death following the
infection (Kendrick, 1973) . The virus has been isolated from the
placenta as early as the eighth day post inoculation, and abortion
can occur as late as the third month post vaccination. There is
also evidence to indicate that the localization of the virus
during the long period from inoculation to abortion is in the
placenta (Kendrick, et al., 1971).
Isolation and Classification of the Viruses .
Bovine Virus Diarrhea Virus . Underdahl, et al_. , in 1957 reported
the isolation of two cytopathic agents but failed to identify the
virus isolates as the causative agents of the disease. Gillespie,
et al . in 1960 identified a cytopathic virus in Oregon, namely
the C24V strain. The National Animal Disease Laboratory (NADL)
strain was isolated by Gutekunst, et al_. in 1962 from the spleen
of a naturally-occurring case of BVD in a closed herd at NADL,
Iowa, and was adapted to porcine kidney cell culture by Malmquist,
et al. in 1965. In sub-clinical infection, the virus was isolated
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from washed leucocytes even when serum antibody was present
(Gutekunst, et al
.
, 1964).
The virus is an RNA-helical-enveloped virus (Castrucci,
1968a, b) . There is considerable variation on reports describing
the size of the virion. Dutta, et al_. (1964) described a size
of 80 nm, while Hafez, et al. (1968) suggested a size between
22-90 nm. Ritchie, et al. (1969) suggested a size of 80-100 nm
particles. Kaess, et al. (1970) and Hornizek (1971) described a
size of 54 nm with an inner core of 24 nm in diameter.
Horzinek, Maess and Laufs (1971) suggested that the virus
should be classified as a togavirus (lipid containing RNA virus
with cubic symmetry of the nucleocapsid) , although BVDV differs
from other togaviruses in their lower sedimentation rate and
desntiy values, their nucleocapsid diameters and the unusual
rosary envelope structure (Horzinek, et al. , 1971)
.
Infectious Bovine Rhinotracheitis Virus . Madin, et al. (1956)
first isolated the virus from nasal secretions of cattle and
cultivated it on bovine embryonic kidney cells. Tousimis, et al .
in 1958 studied the virus by electron microscopy and determined
that the IBR particles produced in bovine kidney cell cultures
had a diameter of 145-150 nm. Classified as a herpes virus
(Armstrong, 1961) the IBRV is a double-stranded DNA (Deoxyribo-
nucleic acid) virus that replicates in the cell nucleus. The
morphology of the virion is also similar to other mature herpes
viral particles (Bruner, et al. , 1973). It has an icosahedral
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capsid with an envelope which appears to contain both viral and
host components as the virus capsid develops in the nucleus.
Vaccination . The development of vaccines for control of BVD-MD
syndrome was based on the attenuation of the BVD virus by serial
passages in rabbits (Baker, et_ a^. , 1958) or in bovine kidney
cell cultures (Coggins, et al
.
, 1961). Commercial vaccines con-
sisting of cell cultures attenuated BVD strain C24V (Bittle,
1968; Coggins, et al . , 1961) or ITADL strain adapted to swine
kidney cell line (PK-15) (Gutekunst, 1968) are usually
multivalent, containing more than one live viral or bacterial
component (Baker, et al., 1958; Bittle, et al., 1968; and Tamoglia,
1968) . Unfortunately, ever since the live attenuated vaccines
were marketed in 1964, it was observed that they were often
accompanied by post-vaccinal reactions in animals (Clark, 1968;
McKercher, 1968; Peacock, 1968; Peter, et al. , 1967; and Rosner,
1968) or were contaminated with other viral agents (KcKercher,
1968; Peacock, 1968; Tamoglia, 1968). Evaluation of the efficacy
of BVD vaccines is difficult because experimentally produced
disease is mild whether challenged via the respiratory route
(Kills et al., 1968; Tyler, et al., 1968), or through the intra-
venous route (Malmquist, 1968; Tyler, et al., 1968). A soluble
antigen vaccine was investigated by Fernelius, e_t al_. , 1971 and
vaccinated calves developed high titer of neutralizing antibodies
against BVD virus. Fernelius, et al^. (1972) studied the evalua-
tion of beta-propiolactone inactivated and chloroform-treated
virus vaccines against bovine viral diarrhea-mucosal disease.
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and reported that it was effective in high antibody production
in animals. In both these methods, two injections were recom-
mended to stimulate antibody response sufficient to protect
cattle. However, McClarkin, et aJ. (1975) demonstrated that if
a killed vaccine was concentrated ten-fold only one injection
was sufficient to elicit the immune response which protected the
fetus in pregnant cattle experimentally exposed to BVDV.
Phillips, et al. (1975) attenuated BVD in continuous porcine cell
line (JS-PK 278) with good immunization results and without post-
vaccinal reactions.
Infectious Bovine Rhinotracheitis Virus Vaccine . The first IBR
vaccine developed was a modified live vaccine by Swartz, et al .
in 1957 and was intended for intramuscular inoculation. This
vaccine, which is still in use, has some disadvantages. It is
contraindicated for use in pregnant animals and if used on calves
less than six months old a second vaccination is essential because
of the possibility of interference by colostrally acquired maternal
antibodies. Apart from abortions the use of live vaccines for
intramuscular use has also resulted in other problems. In 1971
there was evidence suggesting that IBR-vaccinated calves shed
vaccine virus which then infected pregnant dams (Kelling, et al .
1973; Searl, R. D., 1971). Despite the controversy the intra-
muscular live virus vaccine is still widely used and the recom-
mendations for revaccinating cattle after the first vaccination
is varied among practicing veterinarians.
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In an attempt to stimulate both local and parenteral defense
mechanisms a modified live virus intranasal vaccine was introduced
in 1969 by Todd, et_ al. Unlike vaccines for intramuscular use
that can cause abortion, it has been claimed that the intranasal
vaccines are usually safe for pregnant cattle (Kahrs, et al.
,
1973; Todd, et al., 1976; Todd, at al. , 1972; Todd, et al., 1971).
McKercher, et ai_. (1971) reported no distinct advantage of intra-
nasal vaccination over parenteral injection. In studies related
to the development of the vaccine, interferon production was
detected in vaccinated animals and they were protected when
challenged with virulent IBRV 4 0-72 hr. post-vaccination (Todd,
et al., 1971). It is also claimed that intranasal vaccination of
attenuated IER vaccine virus into calves with maternal antibodies
elicited active immunity (Todd, 1973) . However, intranasal vac-
cination is laborious as head restraint is necessary and occasion-
ally vaccinated cattle develop fever, excess nasal discharge and
intranasal plaques from vaccination (Kahrs, et al^. , 1973).
Production of inactivated IBRV vaccine is one approach to
eliminate the problems observed in animals given live modified
vaccines. Inactivated IBR vaccine has been available inter-
mittently in combination with a bacterin containing two Pasteurella
species and inactivated parainf luenza-3 vaccine, but the immuno-
genic response to it has been poor (Matsuoka, e_t al_. , 1972,
Schipper, et al., 1975). However, inactivated vaccines prepared
by addition of an adjuvant have produced adequate antibody titres
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in animals. Kolar, et al . , 1972, using formalin-killed polyvalent
vaccine produced high antibody levels in cattle.
Juhasz, et al. (1974) using formalin-killed IBRV vaccine
which was adjuvated with aluminum-hydroxide gel adsorbent pro-
duced high titers of serum antibodies that protected calves to a
large quantity of virus given simultaneously by intramuscular,
intratracheal routes by spraying on the nasal mucosa and by
scarification into vaginal mucosa. The symptoms were mild and
of short duration.
Haralambiev (1976) used inactivated IBR vaccine prepared by
ethanol and saponin treatment (Haralambiev, et al^. , 1967) into
the nasal mucosa and demonstrated production of antibodies and
interferon in the nasal discharge. Vaccinated animals resisted
challenge with virulent virus. Animals given subcutaneous injec-
tion of the same preparation developed clinical illness following
the challenge, thus supporting the efficacy of submucosal
vaccination.
Blastogenesis Studies . In recent years, protection of the animals
to infection with microorganisms have been focused not only on
the humoral aspect of the immune system but also on the production
of cell-mediated immunity (CMI) . One of the methods of measuring
CMI is to study blastogenesis of lymphocytes by mitogenic
substances, i.e. PEA which is a non-specific mitogen as described
for the first time by Nowell (1960) . The stimulation of lympho-
cytes by PHA results in their transformation, termed as blasto-
genesis and is characterized by a rise in the synthesis of
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deoxyribonucleic acid (DNA) reaching a maximum after 72 hrs.
incubation. Blomgren, et al. (1971) and Janossy, et al. (1971)
have shown that PHA stimulates selectively thymus-dependent
lymphocytes (T lymphocytes)
.
In earlier studies lymphocyte response to mitogens was
evaluated microscopically on the basis of cell morphology.
Recently Sorensen, et al. (1969) have developed a method for
measuring the incorporation of H-thymidine into stimulated
cells. At present a number of methods for quantitative assessment
of lymphocyte response to PHA are available (Phillips, ejt al. ,
1970; Fernald, et al., 1971; Fauguet, 1976; Lazary, et al., 1974).
BVDV and Cell-Mediated Immunity . Necrotic foci can be observed
in the lymphatic tissues like lymph nodes, spleen, and thymus of
cattle fatally infected with BVD virus. Gross lesions also
include destruction of Peyer's patches in the small intestines
and loss of differentiation between cortex and medulla in lymph
nodes. There is severe leukopenia and anemia which may persist
for weeks (Blood, et al. (1963). The responsiveness of lympho-
cytes to PHA was depressed by addition of viable bovine virus
diarrhea virus into cell cultures. This phenomenon was not
observed when heat-killed or UV-irradiated virus was used
(Muscoplat, et_ al . , 1973). Abnormalities in surface immuno-
globulin of circulating lymphocytes from animals with chronic
bovine virus diarrhea have been studied (Muscoplat, et al . , 1973)
and there are indications that the infected animal has a possible
metabolic defect resulting in inability of lymphocytes to secrete
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immunoglobulins. Calves immunosuppressed with corticosteroid
did not respond to BVDV for antibody production and were con-
sequently not protected against challenge with the virus.
However, calves with passive BVD antibodies, when given cortico-
steroid were protected (Shope, et al
.
, 1976). These results may
point out to a major role of humoral antibodies in protection of
calves from BVDV. Popisil, et al. (1976) experimentally infected
calves with BVDV and showed a decline in the phytohemagglutin
responsiveness of lymphocytes from the infected calves, which
again tends to support the evidence that the BVDV is an
immunosuppressant.
IBRV and CMI . Rouse, et al. (1974) studied blastogenesis of
peripheral blood lymphocytes of cattle immunized or infected with
IBRV. They measured the uptake of H-TdR in lymphocytes after
stimulation with DV-inactivated IBR virus. The specificity of
the blastogenic response was demonstrated as cells from animals
immunized with IBR failed to be stimulated with two other non-
specific herpes virus antigens (herpes simplex and equine rhino-
pneumonitis viruses) . IBR specific antibodies also inhibited the
uptake of H-thymidine into cell cultures. The specificity of CMI
response to IBR was further demonstrated by preventing the produc-
tion of CPE by IBR virus in cell cultures in the presence of
stimulated lymphocytes (Babuik, e_t al . , 1974).
Corticosteroids . Corticosteroids are endogenous hormones secreted
by the adrenal cortex, which have multiple physiological functions,
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such as control of carbohydrate metabolism, acting as anti-
inflammatory agents and regulating the number of circulating
lymphocytes. At concentrations higher than normal physiological
levels, corticosteroids change the profile of circulating white
blood cells. There is a significant decrease in the absolute
number of lymphocytes, monocytes, and eosinophils, with an
increase in the number of circulating neutrophils (Fauci, et al.
,
1974; Yu, et al., 1974). Yu, et al. (1974) also reported that
the number of T lymphocytes decreased to a greater extent as
comparedto B lymphocytes, thus having a direct bearing on the
immune system. Nowell (1961) described the inhibition of mitotic
activity of normal human lymphocytes cultures by prednisolone
21-phosphate and established a direct relationship between the
concentration of steroid and percent decrease in mitotic activity.
Roath and Cuppari (1965) suppressed the in vitro lymphocyte
transformation by addition of dexamethasone , hydrocortisone,
cortisone, and prednisolone. Aldosterone, hydroprogesterone and
estradiol had no effects. It had also been observed by Coburg,
et al . (1970) that skin test reactivity is decreased to a variety
of antigens applied two hours after a high dose of corticosteroids.
In addition to the suppression of T-cell function, Peter (1971)
reported that corticosteroids diminish the effects of T-cell
cytotoxicity by interfering with the effect of lymphotoxin on
target cells.
Corticosteroids also affect the humoral response but to a
lesser degree. High levels of corticosteroids over a period of
time significantly suppress the production of immunoglobulin-G
(IgG) in the bone marrow (Butler, 1975). High doses of cortico-
steroids depressed the production of antibodies whereas physio-
logic levels stimulated the immunoglobulin production (Smith,
1972; Ambrose, 1970)
.
Corticosteroids and Binding Sites . Munck and Brinck-Johnson
(1968) observed that rat thymocytes had well-defined steroid-
binding sites and explained the kinetics of the binding process
by the following mechanisms: the first, non-specific binding is
independent of the concentration of the steroid and is peculiar
to each hormone. The second, which is the specific binding, is
concentration-dependent and directly related to the glucocorticoid
activity. The specifically bound hormone elutes very slowly at
37° C when exposed to 0.9% saline, but there is no elution at
4° C. It was indicated that the specific binding is directly
related to the activity of the steroid in the cell (Munck, 1968).
Corticosteroids and Bovine Respiratory Diseases . During condi-
tions of stress in cattle, like overcrowding in feedlots or
transport, the concentration of corticosteroids in blood may be
elevated up to ten-fold or more (Ray, et aJ . , 1972; Volkes,
et al. , 1973). IBRV which often produces subclinical infection
in cattle (Snowdon, 1965) reappeared in time of stress. By
administration of corticosteroid, Sheffy, et al. were able to
recover IBRV from secretions and tissues of respiratory tract
of cattle. Isolation and recrudescence of IBRV following
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hormonal administration were subsequently shown by other workers
(Sheffy, et al. , 1972; Sheffy, et al. , 1973; Davies, et al .
,
1973; Davies, et al., 1974). In vitro studies done by Hall,
et al. (1977) revealed a ten to twelve fold increase in IBRV
progeny in cells treated with corticosterone acetate. Ehope,
et al., (1976) potentiated the severity of BVDV infection in
calves by administration of dexaraethasone.
2SECTION III
(Part I)
STUDIES ON BOVINE RESPIRATORY DISEASES
1. Immunological Responses of Calves to IER and BVD Vaccines
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Abstract
Twenty-four calves vaccinated with a commercial polyvalent
modified live vaccine against infectious bovine rhinotracheitis
virus (IBRV) , bovine virus diarrhea virus (BVDV) , and parainflu-
enzal virus, were studied for humoral and cellular immunity.
Maximum serum antibody titers of 1/80 and 1/160 were detected
against IBRV and BVDV, respectively. However, no cell mediated
immune response was detected by lymphocyte blastogenesis studies.
Formalized inactivated vaccines with Freund's incomplete
adjuvant prepared against IBRV and BVDV were inoculated into
two calves. Serum antibody response was observed one week after
inoculation reaching maximum titers of 1/640 and 1/1280 between
six to nine weeks against IBRV and BVDV, respectively. In addi-
tion, cell mediated immune response was also evident in the calf
inoculated with IBRV inactivated adjuvated vaccine as indicated
by incorporation of H-thymidine into lymphocytes stimulated by
specific virus antigen.
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Introduction . The bovine respiratory disease complex is one of
the most serious disease problems of the cattle industry in the
United States (McKercher, 1968) . The etiology of the disease is
complex, but it is now generally accepted that a number of viral
agents, bacteria and mycoplasmas may be involved (Omar, 1966;
Rosenquist, et al^. , 1970; Rosenquist, ejt al
.
, 1974; Sanders,
e_t a^L. , 1964). Among the known pathogens, bovine virus diarrhea
virus (BVDV) and infectious bovine rhinotracheitis virus (IBRV)
have received considerable attention due to their wide distribu-
tion and the clinical disease they cause in cattle of all ages.
Vaccines against IBR and EVD have been available for the
past decade but have been the subject of controversy because of
their post-vaccinal syndromes (Clark, 1968; Peacock, 1968;
McKercher, 1968; Peter, et al., 1971). Kelling, et al., (1973)
and Searl (1971) reported the shedding of vaccine virus from
calves vaccinated intramuscularly with IBRV vaccine. An IBRV
vaccine developed for intranasal use (Todd, et al. , 1974) has
been claimed to afford early protection, however McKercher, et al.
(1971) did not find any added advantages attributed to internasal
vaccination. Inactivated vaccines have been available for use
against both IBRV (Matsuoka, et al
.
, 1972; Kolar, et al., 1974;
Haralambiev, 1976) and BVDV (Fernelius, et al,, 1972; McClarkin,
et al
. , 1975) but the duration and type of immunity conferred by
inactivated viral vaccines have not been illucidated.
The present study was undertaken to investigate the immune
response in animals inoculated with live or inactivated virus
vaccines.
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Materials and Methods .
Animals . Twenty four calves, one to one and a half years old at
the dairy farm, Kansas State University, were immunized against
infectious bovine rhinotracheitis (IER) , bovine virus diarrhea
(BVD) and parainfluenza-3 viruses at three months of age using
Nasalgen. Between eight to twelve months of age they were revac-
cinated by intramuscular inoculation of modified live IBR and
BVD viruses. In addition, six calves (four to five months old)
from farms in the vicinity of Manhattan were selected on the basis
of their susceptibility to IBRV and BVDV or both and were grouped
as follows: Two calves (D3 and 293) : free of serum antibodies to
both IBRV and BVDV were used as control. Two calves (#9083 and
#9100) : free of serum antibodies to BVDV were inoculated with
BVDV vaccine. Two calves (#1859 and #1861) : free of serum anti-
bodies to IBRV were incoulated with IBRV vaccine.
Pre-Inoculation Procedures
. Prior to inoculation, body tempera-
tures were established and complete blood counts were determined.
Serum profiles of the animals were studied in the Sequential
Multiple Analyzer (SMA-12) , 12/60 micro (Technicon Instruments
Corporation, Tarrytown, NY) . Both blood and serum analysis were
performed at the Clinical Pathology Laboratory, Department of
Infectious Diseases, Kansas State University.
Cell Culture . Madin Darby bovine kidney (MDBK) cells were grown
and maintained in Minimal Essential Medium (MEM) , Eagles' con-
taining 0.1% sodium bicarbonate, 10% horse serum (H.S., Kansas
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City Biologicals) , and an antibiotic mixture of penicillin
100 units/ml, streptomycin 1 mg/ml and kanamycin 5 ng/ml (PSK)
.
Cells were cultured at 37° C in glass prescription bottles or
in tissue culture dishes.
Viruses. The bovine virus diarrhea virus (BVDV) , National
Animal Disease Laboratory (NADL) strain and infectious bovine
rhinotracheitis virus (IBEV) , Los Angeles (LA) strain were
obtained from ATCC and used in these studies. Both of these
viruses produced cytopathic effects (CPE) on MDEK cells.
Virus Growth . Monolayer cultures of HDBK cells were inoculated
with BVDV or IBRV at a multiplicity of about five Plaque Forming
Units (PFU) and maintained in Medium 199. Cultures were harvested
when 903 cells showed cytopathic effect (CPE) and stored at
-80° C. Following two cycles of freezing and thawing, the sus-
pension was centrifuged at 2,000 g for 30 minutes (mins) at 4 C,
supernatant collected and spun at 100,000 g for five hours in an
ultracentrifuge. The pellet was resuspended in five ml of MEM
and stored in aliquots of 0.5 ml each.
Virus Assay . All viruses were assayed by the method described
by Dulbecco (1952) for animal viruses with some modifications.
0.2 ml of each serial log dilutions of virus was inoculated in
duplicate MDBK monolayers in 60 x 15 mm tissue culture dishes.
Following one hour adsorption at 37 C, cultures were overlaid
with eight ml of a mixture of 2% purified agar and 2 X MEM with
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5% H.S., and further incubated. Monolayers were stained with
the media mixture containing 0.01% neutral red after appropriate
incubation of inoculated cultures (three days for IBP.V and four
days for BVDV) . Plaques were counted the following day and
recorded as PF"/ml
.
Detection of Serum Antibodies by Plaque Reduction Method . Two
fold dilutions of heat inactivated serum were mixed with an
equal volume of BVDV or IBRV to contain 100 PFD/0.2 ml of the
mixture. After one hour incubation at 25 C, 0.2 ml of the
virus-serum mixture was inoculated in duplicate plates of MDBK
cell monolayers and adsorbed for one hour at 37° C. Plaque
assay was done as described previously and the serum titers on
the basis of 50% reduction in PFU's were recorded.
gInactivation of Viruses by Formaldehyde . BVDV, 1.5 x 10 to
3 x 10 8 PFU/ml and IBRV, 1 x 10 9 to 3 x 10 9 PFU/ral were each
treated with a final dilution of 1:1000 of formaldehyde. The
mixture was incubated at room temperature for six hours, then
overnight at 4 C and dialyzed in a 1/4 inch dialyzing tubing
for 24 hours at 4 C with three changes of Phosphate Buffered
Saline (PBS) . The formalized virus was tested for complete
inactivation by plaque assay.
Preparation of UV Irradiated Viruses . BVD and IBR viruses were
inactivated by placing one ml of 1 x 10 PFU/ml in a 60 x 15 mm
dish and exposing for five minutes to a source of U.V. light
(U.V. Germicidal Sterilamp, G30T8, 30 watt, Westinghouse Electric
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Co., Bloomfield, NJ) at a distance of 10 cms. The virus was
tested for total inactivation by plaque assay following U.V.
treatment.
Inoculation of Calves with Formalized Vaccines . Calf #1859 and
calf #9083 were inoculated intranasally (IN) with 1.5 x 10 PFU
Q
and 1 x 10 PFU of formalized IBRV and BVDV, respectively.
Control calf #D3 was sham inoculated with one ml of formalized
cell lysate (from MDBK cells prepared in Medium 199)
.
Three weeks post IN inoculation, one ml of formalin
ginactivated IBRV (3 x 10 PFU/ml) and three ml of formalin
inactivated EVDV (3 x 10 PFU/ml) were homogenized with equal
volumes of Freund's incomplete adjuvant (Crand Island Biological)
and administered intramuscularly (IM) in the gluteal muscles to
the respective animals. Control calf received a homogeneous
mixture of cell lysate and Freund's incomplete adjuvant.
Inoculation of Modified Live Vaccines . Calf #1861 was inoculated
IN with modified live IBRV (Nasalgen I, Monovalent, Serial 511),
and calf #9100 inoculated IM with BVD monovalent vaccine. Both
vaccines were kindly provided by Dr. Donald Todd, Jensen-Salsbery
Laboratory, Kansas City, MO) . Uninoculated calf #293 served as
control.
Post-Inoculation Procedures . Body temperatures and hematologic
norms were followed as previously described and calves were
observed regularly for any abnormal signs. Nasal swabs and serum
samples were collected at weekly intervals.
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Testing of Nasal Secretions . Wooden applicators with sterile
cotton tips were introduced in both nostrils and kept in five
ml of cold PBS. Suspensions of nasal swabs (0.2 ml) were
inoculated into duplicate cultures of MDBK cells and passaged
three times in MDBK cells to observe CPE, if any, due to the
presence of virus. Specificity of virus isolates was determined
by plaque reduction test.
For detection of specific virus neutralizing factors, nasal
secretion samples in five ml cold PBS were concentrated 5X in
Minicon concentrators B15 (Amicon Corporation, Lexington, MA)
and . 2 ml was incubated with specific virus for one hour at
25° C and plaque assayed. For detecting non-specific virus
neutralizing factors, monolayers of MDBK cells were treated
overnight with 0.2 ml of 5 X concentrated sample and challenged
the following day with 50-100 PFU of appropriate virus and
plaqued. (IBRV was used as non-specific virus for EVD vaccinated
calves and vice versa)
.
Isolation of Lymphocytes by Ficoll Isopaque Gradient . The iso-
lation procedure included centrifugation of heparinized blood
to obtain buffy coat cells, which were carefully aspirated with a
pasteur pipette. The cells were suspended in three ml of PBS,
gently overlaid on four ml of Ficoll Isopaque (Winthrop
Laboratories, MY) (density 1.077 gm/ml) and centrifuged at 400 g
for 20 minutes. Lymphocytes were collected by aspirating the
layer of cells at the interface between the Ficoll and PBS.
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Isolation of Bovine Lymphocytes by Lymphoprep . Cells from the
buffy coat were recovered as described and resuspended in three
ml of PBS and gently laid on lymphoprep (Nyegaard and Co., Oslo,
Norway), which is a mixture of 9.6% sodium metrizoate and 5.6%
Ficoll.
Lymphocytes were recovered from the interface after centri-
fugation as described earlier.
Isolation of Bovine Lymphocytes by Distilled Water Technique .
Lymphocytes were isolated by the method described by Rossi, et al .
(1977) with some modifications. Peripheral blood was collected
by venipuncture in heparinized containers (five units of heparin/
ml of blood) . Five ml of blood was treated with 10 ml of dis-
tilled water (not deionized) for 15-20 seconds to lyse erythro-
cytes, followed by a treatment with 10 ml of 1.7% sodium chloride
solution to restore isotonicity. The mixture was centrifuged for
10 minutes at 200 g. The procedure was repeated to completely
eliminate RBC's. The recovery of viable mixed lymphocytes as
determined by 0.04% trypan blue exclusion method was more than
99% by this procedure. Cells were washed and suspended in 10 ml
of RPMI Medium 1640 (Roswell Park Memorial Institute Medium 1640)
with PSK. In the present study, this technique was adopted for
isolation of lymphocytes.
Separation of Bovine Mononuclear Cells . For separation of mono-
nuclear cells, essentially the method of Julius, et al. (1973)
was adopted. Nylon fiber from Fenwall Leukopaks (Fenwall,
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Deerfield, IL) was washed in 0.2N hydrochloric acid for two
hours and allowed to dry. 0.2 to 0.3 grams of this nylon fibre
was packed in a six ml capacity plastic syringe up to the four
or five ml mark and sterilized. The column was flushed with
RPMI containing 10% calf serum (CS) free of IBR and BVD anti-
bodies and placed in a CO_ incubator one hour at 37 C.
Mixed lymphocytes 5 x 10 cells suspended in one ml of warm
RPMI were gently overlaid on the column and incubated for 45
minutes. The mononuclear cells were eluted from the column with
dropwise addition of a total volume of 20 ml warm RPMI medium
and collected in a tube.
Isolation of Macrophages . Mixed lymphocytes were suspended in
RPMI with 10% C.S. at a cell concentration of about 5 x 10
cells/ml. About 1.5 to two ml of this suspension was dispersed
in 60 x 15 mm tissue-culture plastic dishes and incubated for
30 minutes to allow macrophages to settle and adhere to the dish.
The medium was then discarded and replaced by two ml of RPMI with
10% C.S. and reincubated for 3 minutes. This procedure was
repeated two to three times to eliminate any nonadherent cells.
Macrophages were obtained by scraping the layer of adherent cells
with a sterile rubber policeman.
Preparation of Lymphocyte Cultures for Blastcgenesis Studies .
Duplicate or triplicate cultures, each containing 1 x 10 cells
were suspended in two ml of RPMI with 10% C.S. and Phytohemag-
glutinin (PHA, Lectin type 'V, Sigma Chemical, St. Louis, MO)
32.5 ug/ml or 0.2 ml of 1 x 10 6 PFU/ml of U.V. treated virus was
added to the cultures. Following 48 hours incubation, 0.1 ml
media containing 1 uCi 3H-thymidine ( H-TdR, specific activity
5 Ci/mmole) was added. After a further incubation of 24 hours,
the cultures were centrifuged, washed three times with cold
Phosphate Buffered Saline (PBS) and precipitated with 5% tri-
chloroacetic acid (TCA) . They were left on ice bath for 10 to
15 minutes and the acid insoluble precipitates were collected
on glass fiber filters (GF/C, 2.4 cms/ Whatman, England) In a
sampling manifold (Millipore Corporation, Model 3025, Bedford,
MA) . Tubes were washed twice with 5% TCA and contents trans-
ferred on filters, which were placed in scintillation vials con-
taining 10 ml of scintillation fluid. Samples were counted for
10 minutes in a scintillation spectrometer (Packard Tri-Carb,
Model 3002, Downers Grove, IL)
.
Results .
Clinical Observations . Following intranasal or intramuscular
inoculation of inactivated vaccines, none of the calves showed
signs of illness. Appetite was normal and body temperatures
remained in the range of 101 to 102° F. There were no changes
observed in white blood cell counts after vaccination.
The calf vaccinated intranasally with Nasalgen 1 had a
slight increase in body temperature (103.8 F) on the fourth
day post-vaccination which returned to normal the following day.
The calf that received modified live BVD vaccine IM did not show
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any signs of illness. In both calves, no changes in white blood
cell counts were observed after vaccination.
Virus Excretion . Attempts to isolate virus from nasal swabs
after the administration of inactivated vaccines were negative.
However, IBR virus was isolated from calf 1861 vaccinated with
Nasalgen 1 on day three and subsequently on day four (Table 1)
.
Specificity of the virus was determined with IBR and BVD anti-
sera in plaque reduction test.
Assay of Virus Neutralizing Factors in Nasal Swabs . Plaque reduc-
tion assays did not reveal the presence of either specific or
non-specific virus inactivating factors in the nasal swab suspen-
sions of calves following vaccination with either inactivated or
modified live vaccines.
Humoral Response . All the 24 calves from Kansas State University
Dairy Farm had antibodies to IBRV and BVDV. Serum samples from
10 calves were titrated and had IBR and BVD antibody titers of
1/80 and 1/80 to 1/160, respectively. The intranasal vaccination
with inactivated IBRV and BVDV in experimental calves free of
neutralizing antibodies did not produce any humoral response.
Serum samples collected one week after IM inoculation of these
calves with inactivated-adjuvated vaccines produced serum anti-
body titers of 1/160 for IBRV (Figure 1) , and 1/80 for BVDV
(Figure 2) , respectively. The IBR titers gradually increased,
reaching a maximum of 1/640 by the fifth week, declined to 1/320
and remained constant thereafter (Figure 1) . The BVD antibody
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titer reached a peak of 1/1280 on the ninth week and did not
change during the rest of the study (Figure 2)
.
In contrast, maximum serum antibody titers in calves
inoculated with modified live IBR and BVD virus vaccines were
1/80 and 1/640, respectively (Figures 1 and 2).
Lymphocyte Studies . Table 2 demonstrates the percent recovery
of mixed and purified lymphocytes by the methods described.
A maximum recovery of 98% and 30% was observed for mixed and
purified lymphocytes, respectively. Figure 3 demonstrates that
the viability of lymphocytes was 100% upon initial isolation.
The viability of mixed lymphocytes with PHA was 25-35% higher
at 24 and 48 hours than cells without PHA. The number of viable
cells declined to 60% by 72 hours.
Lymphocyte Stimulation by PHA . Figure 4 demonstrates the effect
of different concentration of PHA on the stimulation of
lymphocytes. Maximum stimulation occurred with 2.5 ug/ml of PHA
as indicated by the incorporation of H-TdR in cells. Higher
levels of PHA resulted in decreased uptake of the label. Figure 5
illustrates that the time course of maximum DNA synthesis in
lymphocytes was at 72 hours after addition of 2.5 ug/ml of PHA.
The maximum incorporation of H-TdR in PHA stimulated lymphocytes
when exposed to the label was found to be between 12 and 24 hours
as shown in Figure 6.
Lymphocyte Stimulation by Specific Viral Antigen . The results of
stimulation of lymphocytes from calves by specific viral antigen
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are shown in Tables 3 to 7. Lymphocytes from 24 dairy calves
inoculated with live modified vaccine did not respond to stimu-
lation by either IBR or BVD virus antigen (Table 3)
.
Mixed lymphocytes obtained from calf vaccinated with
inactivated IBR virus and adjuvant were stimulated by IBR virus
antigen as indicated by increase in stimulation index (Table 4).
The stimulation index increased from 1.76 to 7.4 by the third
week reaching a maximum of 20.69 by the 11th week. The mean
stimulation index for the period of study was 11.53.
Lymphocytes of calves inoculated with inactivated BVD virus
and adjuvant and IBR or BVD modified live vaccines did not respond
to stimulation by specific virus antigens (Tables 5-7) . Their
stimulation indices did not change appreciably throughout the
course of studies (mean stimulation indices ranged from 0.7 to
1.4) .
Effect of Adherent Cells or. Lymphocyte Stimulation . Nylon wool
purified lymphocytes from calf vaccinated with inactivated IBR
and adjuvant were not stimulated by IBR antigen. However, when
they were mixed with a population of adherent cells (macrophages)
,
stimulation was evidenced by blastogenesis and incorporation of
3H-TdR (Figure 7) .
Discussion . The absence of clinical signs in calves vaccinated
with inactivated IBRV and BVDV is in accordance with the findings
of other workers (Fernelius, et_ al. , 1971; Fernelius, et al.,
1972; McClarkin, et al., 1975; Kolar, et al . , 1972; Juhasz, et al.,
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1974; A. Schipper, e_t a^. , 1975). The rise in temperature
recorded in calf given live modified IBR vaccine and subsequent
recovery of the virus from its nasal passages indicated that the
IBR virus replicated at the sites of entry. Recovery of IBR
virus from nasal swabs of calves following vaccination with
Nasalgen has also been reported by Hyland and Easterday (1975)
.
The replication of virus observed in our studies may have con-
ferred early protection to the animal by means of interferon
synthesis before the production of humoral immunity (Todd, et al.
,
1971). Contrary to the findings of Peter, et al., 1967; Bittle,
1968; the virus shedding was not observed in calf vaccinated
with modified live BVDV vaccine, and the vaccination was not
accompanied by any untoward clinical reactions.
Calves inoculated with inactivated adjuvated vaccines demon-
strated higher serum antibody titers as compared to calves
immunized with modified live virus vaccines (Figures 1 and 2)
.
It is also evident from Figure 1 that vaccination with inactivated-
adjuvated IBR virus brought about an earlier serum antibody
response as opposed to Nasalgen 1. Fernelius, e_t a^. (1971, 1972)
reported high antibody response with soluble and inactivated BVD
virus vaccines after two or more vaccinations; and McClarkin,
et al. (1975), using killed BVD virus, elicited adequate humoral
response (1/256-1/512) by inoculation of a 10-fold concentrated
BVDV antigen. In our study, a single inoculation of inactivated
BVD virus with adjuvant produced a titer of 1/1280 serum anti-
bodies (Figure 2) . There have been many investigations as regards
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to the use of inactivated IER vaccines. Schipper (1975) reported
poor and delayed serological response following administration of
inactivated I3RV vaccine; Haralambiev (1976) produced secretory
antibodies and interferon in nasal mucosa, but low serum anti-
body titers with saponin-ethanol inactivated IBRV. Kolar, e_t al_.
(1972) , demonstrated high antibody titers by two inoculations of
formalized inactivated IBRV (Colorado strain) with adjuvant, while
Juhasz used inactivated IBRV adjuvated with aluminum hydroxide
gel adsorbent in calves and showed high degree of serum antibodies.
In our study, a single inoculation of inactivated-adjuvated IBRV
elicited a rapid humoral response which reached a high antibody
titer of 1:640 by the fifth week. The mode of action of oily
adjuvants is well documented and described by many workers.
McKinney, et al. (1960) demonstrated that oily adjuvants caused
slow release of virus over long period of time and Hobson (1973)
showed that the amount of virus needed to produce a maximum
humoral response was much less when administered with an adjuvant.
Influenza virus initiated a high antibody response when given
with adjuvant 65 (Woodhour, et al. , 1969) . Higher serum anti-
bodies response of inactivated-adjuvated vaccine in our studies
may have been due to a similar mode of action as described by
these investigators.
It was surprising to find that one of the control calves,
previously free of BVD serum antibodies, showed titers of 1/8
after inoculation of cell lysate and adjuvant. Tests in rabbits
using the lysate showed no viral contamination whatsoever
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(Table 8) . It is possible that the presence of adjuvant in the
lysate might have changed the expression of previously undetectable
serum antibody, or affected the ratio of various antibody classes
resulting in appearance of humoral antibodies (White, 1967).
The maximum stimulation of lymphocytes was obtained when a
concentration of 2.5 ug/ml of PHA Type V was used. Muscoplat,
et al. (1974) reported a maximum stimulation of bovine lympho-
cytes with a concentration of 5 ug/nl of PHA (Type M) , while
other workers have obtained best stimulation at concentrations
lower or higher than 2.5 ug/ml using different types of PHA
preparations (Popisil, et al., 1976; Gerber, et al., 1974).
The optimum culture period of 72 hours and the time of maximum
uptake of 3H-TdR when PHA stimulated cells are exposed to the
label are similar to the findings of other investigations
(Muscoplat, et al., 1974; Rouse, et al., 1974).
Cultures of mixed lymphocytes from calf vaccinated with
inactivated-adjuvated vaccine were stimulated in vitro with
specific IBR virus antigen suggesting the presence of cellular
immunity (Table 4). Rouse, et al. (1974) have investigated the
blastogenic response of IBR-primed lymphocytes with specific
virus antigen. In their studies, lymphocytes were obtained
from calves that were initially injected with a virulent strain
of IBRV (Colorado strain), and Freund's complete adjuvant,
followed by monthly intramuscular administration of live IBR
virus, or calves infected intranasally with virulent virus.
However, the mycobacterium antigen present in the adjuvant used
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by them might have influenced the stimulation seen. In our
studies specific stimulation was obtained by inoculation of a
calf with a single dose of inactivated IBRV with Freund's
incomplete adjuvant, and the stimulation index remained at high
levels till the completion of this study (Table 4).
Rouse, et al
.
, 1974 observed that purified lymphocytes from
nylon wool column were specifically stimulated by IBRV antigen.
In the present study purified lymphocytes from vaccinated calf
failed to respond to IBRV antigen in contrast to the findings of
Rouse, et al. (1974) . However, when adherent cells (macrophages)
were added, blastogenic effect was restored. This finding is in
accordance with that of Alder and Rabinowitz (1973) , indicating
that macrophages are important in eliciting the cell mediated
immune response
.
These prototype studies have demonstrated that serum anti-
bodies to both IBRV and BVDV may be elicited by a single inocu-
lation of inactivated viruses with Freund's incomplete adjuvant
and the antibody titers were relatively greater as compared to
humoral response observed with modified live vaccines. In
addition, cell mediated immune response was also evident in calf
vaccinated with inactivated IBR virus with adjuvant. It is sug-
gested that further studies on the role of inactivated vaccines
in producing humoral and cell mediated immunity should be done
using biologically degradable adjuvant and a larger sample size
of animals.
Figure 1. Serum antibody titers of calves vaccinated with IBRV
vaccines . Two fold dilutions of heat inactivated
serum were mixed with an equal volume of IBR virus
to contain 500 PFU/0.2 ml of the mixture. After one
hour incubation at 25 C, 0.2 ml of the serum virus
mixture was inoculated on duplicate monolayers of
MDBK cells and adsorbed for one hour at 37° C.
Monolayers were overlaid with a mixture of 2 X MEM
and 2% purified agar containing 5% horse serum. After
three days of incubation, monolayers were stained with
media-agar mixture containing 0.01% neutral red, and
serum antibody titers were determined on the basis of
50% reduction in the number of PFU as compared to
virus control. Symbols: —O— Modified Live Virus
Vaccine; —•— Formalized Virus Vaccine with Adjuvant.
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Figure 2 . Serum antibody titers of calves vaccinated with BVDV
vaccines . Two fold dilutions of heat inactivated
serum were mixed with an equal volume of BVD virus
to contain 100 PFU/0.2 ml of the mixture. After one
hour incubation at 25° C, 0.2 ml of the serum virus
mixture was inoculated on duplicate monolayers of
MDBK cells and adsorbed for one hour at 37 C.
Monolayers were overlaid with a mixture of 2 X MEM
and 2% purified agar containing 5% horse serum. After
four days of incubation, monolayers were stained with
media-agar mixture containing 0.01% neutral red, and
serum antibody titers were determined on the basis of
50% reduction in the number of PFU as compared to
virus control. Symbols: —O— Modified Live Virus
Vaccine; — — Formalized Virus Vaccine with Adjuvant.
41
2560
-.
• o *
o o o
5 10
WEEKS POST VACCINATION
Figure 3. Viability of lymphocytes in culture . Mixed or puri-
fied lymphocytes, 1 x 10 cells were suspended in
1.9 ml R.P.M.I. with 10% calf serum. Media (0.1 ml)
containing or lacking PHA was added to cultures that
were incubated at 37° C. At 0, 24, 48, 72 and 96
hours, samples from cultures were mixed with 0.04%
trypan blue, and examined under the microscope.
Cells which excluded the dye were regarded as viable
and counted on a hemocytometer. Symbols: — —Mixed
Lymphocytes with PHA; —— Mixed Lymphocytes without
PHA; —©—Purified Lymphocytes with PHA; A Purified
Lymphocytes without PHA.
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Figure 4. Stimulation of purified lymphocytes by PHA .
Phytohemagglutin in concentrates of 1, 2, 2.5, 5, 7.5
and 10 ug/ml was added at hour to lymphocytes
cultures containing 1 x 10 cells in two ml of RPMI
with 10% calf serum. At 43 hours, 1 uCi of 3H-TdR
was added and cultures terminated at 72 hours. Cells
were harvested and processed for counting in scintil-
lation spectrometer.
45
20
15'
1
T"
2
i
2.5
PHA
T
5Wm!)
—
r
7.5
—
n
10
Figure 5. Time course of DKA synthesis in PHA stimulated
lymphocytes . Lymphocyte cultures containing 2.5
ug/ml of PHA were incubated for different lengths
of time up to 96 hours. Samples were labelled
with H-TdR 24 hours prior to harvest. At termi-
nation of culture, cells were processed for counting
and specific activity on the basis of cell numbers
(DPM/10 5 cells) was determined. Symbols: — — Mixed
Lymphocytes; —Q— Purified Lymphocytes.
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Figure 6 . Incorporation of H-thymidine in PEA stimulated
lymphocyte . Lymphocyte cultures containing 2.5
ug PHA/ml were incubated. Beginning at 48 hours,
3H-TdR was added to different sets of cultures
at four hour intervals. All cultures were har-
vested at 72 hours, processed and DPK's determined.
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Figure 7. Stimulatiop of lymphocytes (mixed and purified) by
specific virus antigen . Mixed and purified lympho-
cytes, 1 x 10 cells, obtained from calf vaccinated
with formalized-adjuvated vaccine were stimulated
in vitro by IBRV (D.V. irradiated) . A set of puri-
fied lymphocytes cultures, to which macrophages from
the same animal were added, was treated in a similar
way, and the stimulation indices of the different
cultures were determined after the samples were
processed and DPM calculated. Symbols: Q Mixed
Lymphocytes; ^ Mixed Lymphocytes + IBRV Antigen;
|>T] Mixed Lymphocytes + BVDV Antigen; [[J]] Purified
Lymphocytes; | Purified Lymphocytes + IBRV Antigen;
EEj Purified Lymphocytes + Macrophages + IBRV
Antigen
.
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TABLE 1
ISOLATION OF VIRUS FROM NASAL SWABS OF VACCINATED CALVES
P.F.U./ml
Days Post Inactivated Modified Live
Vaccination Virus Vaccine Virus Vaccine
BVD IBR
3
4
5
BVD IBR
1 x 10 4
1 x 10 5
£3
TAELE 2
RECOVERY OF BOVINE LYMPHOCYTES BY DIFFERENT METHODS
Method Per Cent Recovery
Distilled Water:
Ficoll Isopaque:
Lymphoprep
:
Nylon Wool Column:*
98
25
20
30
Recovery of purified lymphocytes
TABLE 3
5 4
STIMULATION INDICES OF MIXED LYMPHOCYTE CULTURES
OF IMMUNIZED CALVES FROM K.S.U. DAIRY FARM
Serum Serum
Antibody Antibody
Calves No. Titer Titer S.I.
to IBRV to BVDV
1:80
1:80
1:80
461
462
463
464
466
467
468
469
470
471
472
4 73
474
475
476
477
4 73
480
4Si
482
483
484
4SC
487
24 Dairy Calves
Stimulation Index
1:80
1:80
1:80 1.34
1:160 0.94
— 2.69
— 2.40
1:160 3.56
1:160 2.40
1:160 2.82
1:160 2.39
1:160 2.02
— 0.86
1:160 0.69
— 1.49
— 1.70
— 4.60
— 2.31
— 1.39
— 0.70
— 1.20
— 1.53
— 1.27
1:160 2.00
1:160 1.26
-- 1.32
(IBR)
(0.36)
(1.50)
(2.14)
(1.43)
(1.17)
Mean Stimulation
With IBRV
1.82 (+0.92 S.D.]
1.07
1.08
1.01
0.93
(EVD)
(0.33)
(3.11)
(0.50)
1.05
1.90
1.14
0.69
1.40
1.58
1.33
2.13
1.19
0.74
Index (+S.D.)
With BVDV
1.36 (+0.53 SD)
(2.14)
(1.17)
PPM (cells + antigen )
DPM (cells only)
*S.I. Stimulation Index.
Numbers in parentheses represent stimulation indices of
control calf.
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TABLE 8
DETECTION OF SERUM NEUTRALIZING ANTIBODIES
Percent Virus Neutralized
Treatment
Weeks Post Inoculation
5 9
Rabbit inoculated
with inactivated
BVD + adjuvant
Rabbit inoculated
with lysate +
adjuvant
70 46 53
Rabbit inoculated
with lysate
Uninoculated rabbit
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SECTION IV
(Part II)
STUDY ON BOVINE RESPIRATORY DISEASES
Effect of Steroids on Lymphocytes of Immune
and Non-immune Calves, In Vitro
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Abstract
The interaction of bovine lymphocytes with steroid hormones
demonstrated specific receptors for Cortisol. Increasing con-
centrations of Cortisol (0-5,000 ng/ml) failed to influence the
degree of adsorption of infectious bovine rhinotracheitis virus
(IBRV) or bovine virus diarrhea virus (BVDV) to bovine lympho-
cytes indicating a lack of competition between the steroid and
the viruses for cellular receptors.
Cortisol inhibited the incorporation of H-thymidine ( H-TdR)
in PHA stimulated lymphocytes. Lymphocytes from the calf vac-
cinated with inactivated-adjuvated IBRV were specifically stimu-
lated by virus antigen and the presence of Cortisol in culture
inhibited blastogenesis as indicated by lack of incorporation of
3H-TdR into cells.
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Introduction . Bovine respiratory disease problems are frequently
encountered in crowded animal situations such as in feedlots,
during transportation or under adverse weather conditions. Under
such circumstances, the animals are under stress which may affect
the physiological hormonal balance, often leading to an increase
in the level of serum or plasma Cortisol (V7eiss, 1977; Christison,
G. J., et al. , 1972, 1970). Susceptibility of the host to viral
diseases have been shown to be altered by the increase in steroid
concentrations (Kilbourne and Horsefall, 1951; Shwartzman, et al.,
1952; Kass, et al., 1958; Reinicke, 1965; and Rytel, et al., 1966).
Sheffy, et al. (1973) reported the reappearance of IBRV infection
in animals during times of stress and the recovery of the virus
was demonstrated following administration of corticosteroids
(Davies, et al
.
, 1974). Shope, et al. (1977) observed that admin-
istration of Cortisol resulted in potentiation of EVDV infection
in calves. Both in vitro and in vivo studies revealed that hor-
mones can change the expression of viral genomes in cells
resulting in increased virus synthesis (Joncas, et al
.
, 1977;
Jones, et al.
, 1963). Hall, et al. (1977) demonstrated a ten-
fold increase in IBRV synthesis in cells treated with
corticosterone. In addition, steroid hormones are known to be
immunosuppressive, lympholytic and cause lesions on lymphoid
tissues (Wallnerova, et al., 1971).
The objective of this study was to investigate the inter-
action of IBR or BVD viruses with bovine lymphocytes in the
presence of Cortisol.
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Materials and Methods .
Animals . Six calves, five to six months old, two each immunized
against BVDV or IBRV, and two control calves were used in these
studies. The animals were tested for the production of anti-
bodies to the viruses by 50% plaque reduction method. Serum
antibody titers ranged from 1/80 to 1/1280. The immune status
of the animals has been described in detail in Part 1.
Cells . Madin Darby Bovine Kidney (MDBK) cells were propagated
in Eagles' Minimal Essential Medium (MEM) containing 10% horse
serum as previously described.
Viruses. The bovine virus diarrhea virus, National Animal Disease
Laboratory (NADL) strain, and infectious bovine rhinotracheitis
virus, Los Angeles (LA) strain were obtained from ATCC. Both
viruses produced cytopathic effects in MDBK cells.
Preparation of Radioactively Labelled Viruses . Monolayers of
MDBK cells grown in tissue culture dishes (100 x 20 mm. Falcon)
were infected with IBRV or BVDV at a multiplicity of three to
five Plaque Forming Units (PFU) per cell and maintained in
medium 199, containing 0.25 uCi/ml of either H-thymidine
( H-TdR, specific activity 90 Ci/mmole, New England Nuclear,
Boston, MA) for IBRV inoculated cultures or H-Uridine (specific
activity 23.5 Ci/mmole) for BVD virus infected cells. Cultures
were harvested as previously described, frozen and thawed twice
and centrifuged at 1,500 g to remove the cellular debris. The
supernatant was ultracentrifuged for five hours at 100,000 g.
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The virus pellet was suspended in five ml of MEM and treated
with DNase and RNase at final concentration of 10 ug/ml in IBR
and BVD virus preparations, respectively. The mixture was incu-
bated for 30 minutes at 25° C and ultracentrifuged for 1 1/2
hours at 200,000 g. The pellet was washed in cold MEM to remove
the enzymes, resuspended and dialyzed (1/4 inch dialyzing tubing,
size one, Fisher Scientific, Pittsburgh, PA) against MEM in an
ice bath for three hours and stored at -80 C.
Virus Assay . Viruses were assayed by the method described by
Dulbecco (1952) for animal viruses with some modifications.
(Details of this procedure were described in Part 1.)
Isolation of Bovine Lymphocytes . Bovine lymphocytes were isolated
by the method described by Rossi, et_ al^ (1977) with some
modifications. Peripheral blood was collected in heparinized
containers and treated with distilled water and 1.7% sodium
chloride solution. For separation of mononuclear cells, the
method of Julius, e_t al. (1973) was adopted.
Blastogenesis Studies with PHA and Specific Virus Antigen .
Triplicate cultures, each containing 1 x 10 cells were suspended
in two ml of RPMI medium with 10% calf serum and Phytohemagglutinin
(PHA) 2.5 ug/ml or 0.2 ml of 1 x 10 6 PFU/ml of U.V. inactivated
virus was added to the cultures. Following 48 hours incubation,
3
1 uCi H-thymidme in 0.1 ml media was incorporated. Cultures
were further incubated for 24 hours, centrifuged, washed three
times with cold phosphate buffered saline (PBS) and precipitated
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with 5% trichloroacetic acid (TCA) . The acid insoluble pre-
cipitates were collected on glass fiber filters (GF/C, 2.4 cms)
in a sampling manifold. Tubes were washed twice with 5% TCA,
contents transferred en glass fiber filters that were placed
in scintillation vials and counted.
Adsorption of Steroids to Bovine Lymphocytes . Mononuclear cells
or mixed lymphocytes (5 x 10 cells in two ml of RPMI) were
added to sets of triplicate tubes each containing a mixture of
0.2 uCi of a radioactive hormone and a concentration of the
corresponding non-radioactive hormone. Cultures were washed
twice with cold PBS, cells were transferred on glass fiber
filters in a sampling manifold and subsequently placed in
scintillation vials for counting.
Adsorption of Radioactive Viruses on Lymphocytes in the Presence
of Cortisol . Different concentrations of Cortisol (0-500 ng)
were added to a suspension of mixed or purified lymphocytes
(1 x 10 cells) in triplicate cultures. After four hour incuba-
tion all cultures received a constant amount of H-IBR (1.4 x 10
PFU/ml, 3,000 counts/mins/ml or 3H-BVD (3 x 10 7 PFU/ml, 1,700
counts/mins/ml. Cultures were further incubated for two hours
and were washed twice with cold PBS. The cell pellet was resus-
pended in two ml of PBS and 0.2 ml was saved from each sample for
plaque assay. The remaining cell suspension was transferred on
glass fiber filters and processed as described previously for
counting in scintillation spectrometer.
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Results .
Adsorption of Cortisol Binding to Lymphocytes . Figure 1 illus-
trates that the adsorption of H-cortisol to lymphocytes increased
linearly as a function of cell number. Decreased incorporation of
H-cortisol in the presence of non-radioactive Cortisol (500 ng)
occurred with more than 5 0% reduction in cultures containing 10
million cells.
Specificity of Cortisol Binding to Bovine Lymphocytes . Binding
of radioactive Cortisol to receptor sites on bovine lymphocytes
declined with increasing concentration of non-radioactive hormone.
Reductions of 25-50% in the adsorption of the labelled hormone
was observed with the addition of 5-500 ng of the competing hor-
mone suggesting specificity of binding. There was no difference
in the degree of adsorption of the hormone to cells of control
and vaccinated animals.
Adsorption of Radioactive Viruses to Lymphocytes in Presence of
Cortisol . Tables 1 and 2 illustrate the adsorption of H-IBR or
H-BVD viruses to lymphocytes of control and vaccinated calves
in the presence of varying concentrations of Cortisol. In these
cultures, no appreciable differences were observed in DPM's and
PFU's indicating lack of competition between the viruses and the
hormone for the same cellular receptor sites. Purified or mixed
lymphocytes in these experiments yielded identical results
(Tables 3 and 4) .
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Inhibitory Effects of Cortisol on Lymphocyte Stimulation .
Lymphocytes from both control and vaccinated calves when stimu-
lated for blastogenesis studies in the presence of Cortisol
demonstrated low incorporation (10-15%) of H-TdR (Tables 5-7).
Maximum suppression (90%) of label uptake was observed at the
lowest concentrations (5 ng) used, with no further suppression
at higher levels. Stimulation by specific virus antigen in
cultures from immunized animal demonstrated some degree of
inhibition of blastogenic response in the presence of the
hormone.
Discussion . Munck, et al^. (1968) demonstrated saturation of the
specific binding sites of thymus cells with increase in the con-
centration of the hormone. In our studies, binding of H-cortisol
decreased as the concentration of the competing hormone was
increased (Figure 2) . It seems that a saturation point was
reached at a concentration of 500 ng/ml of the hormone and there
was no further decline in label incorporation at the highest con-
centration (5,000 ng/ml). In the experiment Cortisol bound non-
specifically would elute from cells since all cultures were incu-
bated at 37° C for four hours after addition of the hormone
(Munck, 1968). Thus, the binding of Cortisol to bovine lympho-
cytes was most likely due to the presence of specific receptors
(Figure 2). Eurenius, et al . (1968) reported that the binding
of Cortisol to rat and rabbit thymocytes was related to mean
cell volume. Figure 1 demonstrates that incorporation of
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Since bovine lymphocytes have specific receptors for Cortisol,
an increase in the number of lymphocytes would lead to a higher
number of receptor sites, thus resulting in increased incorpora-
tion of the labelled hormone in cultures as observed in our
experiments (Figure 1)
.
Tables 1 and 2 indicate that Cortisol, IBRV and BVDV have
different receptors on the bovine lymphocyte. The presence of
different concentrations of the hormone did not influence the
adsorption of a constant amount of radioactively labelled virus
as measured by the recovery of DPM's and PFU from cells to both
of control and vaccinated calves. Tables 3 and 4 illustrate no
difference in adsorption of viruses on mixed and purified
lymphocytes, suggesting that the adsorption is mostly an inter-
action between virus and lymphocyte and is independent of the
presence of other cells in a mixed population.
Nowell (1961) reported that Cortisol in concentrations of
10 ng/ml inhibited mitogenesis by PHA in cultures of human
peripheral blood lymphocytes. Muscoplat, et al_. (1975) showed
that corticosteroid given in vivo altered the response of
peripheral blood lymphocytes of calves, as indicated by a decrease
in their response to PHA, in_ vitro . In our studies, we presented
data indicating that the addition of Cortisol, as low as 5 ng per
ml to lymphocyte cultures of calves resulted in a sharp decline
in their responsiveness to both PHA and specific virus antigen
in vitro (Tables 5-7) . It is probable that the nature of inhibi-
tory action produced by Cortisol is of a general type of
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suppression of the lymphocyte rather than an activity restricted
to surface membranes since Cortisol and the IBRV antigen have
been shown to have different receptor sites. The mode of sup-
pression by the hormone has been explained earlier by Feldman,
et al . (1972) ; the steroid-receptor complex is capable of entering
the nucleus and combining with the chromatin which influences the
DNA transcription leading to specific alterations in the cell
functions
.
The recovery of viruses and recrudescence of diseases
reported by earlier workers (Sheffy, et^ al . 1973; Davies, et al .
1973; Cribbs, et al. 1975) following administration of cortico-
steroids or during times of stress when hormonal levels are high,
may be the result of a general suppression of the T-cell function
as observed in our studies, coupled with inhibition of antibody
production as described by Butler (1975) .
In this study, we have demonstrated that bovine lymphocytes
have specific receptors for Cortisol and the adsorption of IBR
and BVD viruses to bovine lymphocytes was not influenced by the
presence of the hormone. The inhibitory action of the hormone
has also been investigated and the data presented, suggest that
the inhibition may be the result of changes at cellular level
brought about by association of the hormone in the cell DNA,
as postulated by Feldman, et al . (1972)
.
Figure 1. Adsorption of H-cortisol to bovine lymphocytes .
Mixed lymphocytes (0.5 to 10 million cells in two ml
RPMI) were added to sets of triplicate tubes con-
taining or lacking 500 ng non-radioactive Cortisol.
A constant amount of H-cortisol (0.2 uCi) was
added to all cultures and incubated for four hours.
Cultures were washed twice with cold PBS and proc-
essed for counting in scintillation spectrometer
and DPM's determined. Symbols: —•— H-cortisol,
—
O
— H-cortisol + 500 ng non-radioactive
Cortisol; —&— cells only.
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Figure 2 . Specificity of adsorption of Cortisol to bovine
lymphocytes . Different concentrations of Cortisol
(0-5,000 ng/ml) were added to a suspension of
5 x 10 lymphocytes cultures containing a constant
3
amount (0.2 uCi) of H-cortisol. Cultures were
incubated for four hours before they were washed
twice with cold PBS and processed for counting
and DPM's determined. Symbols: —9— Control
Calves; —O— IBRV Vaccinated Calves; —&—
BVDV Vaccinated Calves.
73
1 1
5 50 500 5000
CORTISOL (ng/ml)
74
TABLE 1
3..ADSORPTION OF H-BVDV TO MIXED LYMPHOCYTES IN THE
PRESENCE OF DIFFERENT CONCENTRATIONS OF CORTISOL
Mean of Two BVDV Mean of Two
Treatment
Vaccinated Calves Control Calves
DPM PFUDPM PFU
3H-BVDV Only 788 1.15 x 10 3 814 1.1 x 10 3
3H-BVDV + 5 ng Cortisol 815 1.2 x 10 3 826 1.12 x 10 3
3H-BVDV + 50 ng Cortisol 776 1.15 x 10 3 791 1.16 x 10 3
3H-BVDV + 500 ng Cortisol 796 1.21 x 10 3 769 1.13 x 10 3
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TABLE 2
ADSORPTION OF H-IBRV TO MIXED LYMPHOCYTES IN THE
PRESENCE OF DIFFERENT CONCENTRATIONS OF CORTISOL
Treatment
IBR Vacci-
nated Calf Control Calf
DPM PFU DPM PFU
3H-IBRV Only
H-IBRV + 5 ng Cortisol
H-IBRV + 50 ng Cortisol
3H-IBRV + 500 ng Cortisol
1421 3.6 x 10 3
1468 3.4 x 10 3
1419 3.6 x 10 3
1392 3.3 x 10 3
1507 3.6 x 10 3
1448 3.6 x 10 3
1374 3.4 x 10 3
1435 3.7 x 10 3
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TABLE 5
EFFECT OF CORTISOL ON PHA STIMULATED LYMPHOCYTES
76
D.P.M. X 10 3 ( 3E-TdR)
IBRV Vacci-
Treatment nated Calf Control Calf
Cells Only 6.4 5.3
Cells + PHA 808.9 (100%) 119.6 (100%)
Cells + PHA + Cortisol 5 ng 115.7 (14.3%) 5.4 (4.6%)
Cells + PHA + Cortisol 50 ng 111.2 (13.7%) 4.0 (3.4%)
Cells + PHA + Cortisol 500 ng 85.3 (10.5%) 2.7 (2.26%)
The number in parenthesis represents percent incorporation
of 3H-TdR.
TABLE 6
EFFECT OF CORTISOL ON PHA STIMULATED LYMPHOCYTES
79
,3 ,3„
BVDV Vacci-
Treatment nated Calf Control Calf
Cells Only 0.7 3.7
Cells + PHA 62.7 (100%) 18.5 (100%)
Cells + PHA + Cortisol 5 ng 7.5 (11.9%) 2.0 (10.8%)
Cells + PHA + Cortisol 50 ng 7.3 (11.6%) 2.7 (14.5%)
Cells + PHA + Cortisol 500 ng 7.2 (11.4%) 1.6 (8.65%)
The number in the parenthesis represents percent incorporation
of 3H-TdR.
8G
EFFECT OF CORTISOL ON LYMPHOCYTES FROM IBP, VACCINATED
CALF STIMULATED BY SPECIFIC ANTIGEN
PPM X 10 2 ( 3H-TdR)
Cells only 36.7
Cells + IBR 209.6 (100%)
Cells + IBR + Cortisol 5 ng 80.8 (38.6%)
Cells + IBR + Cortisol 50 ng 79.6 (37.9%)
Cells + IBR + Cortisol 500 ng 73.6 (35.11%)
The number in parenthesis represents the percent incorporation
of 3H-TdR.
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APPENDIX
g
Inactivation of Viruses by Formalin . BVDV, 1.5 x 10 to
3 x 10 8 PFU/ml and IBRV, 1 x 10 9 to 3 x 10 PFU/ml were treated
with formalin at final concentrations of 1:1000, 1:2000, 1:4000,
1:8000, 1:16000 and 1:32000 (40% formaldehyde solution, Fisher
Scientific, Fairlawn, NJ) . The mixture was incubated for six
hours at room temperature, then overnight at 4 C and dialyzed
in a 1/4 inch dialyzing tubing for 24 hours at 4 C with three
changes of PES. The virus was plaqued to determine the percent
activity remaining (Figure 1)
.
Inactivation of Viruses by U.V. Irradiation . One ml of BVDV
or IBRV, 1 x 10 PFU/ml was placed in a 60 x 15 nun dish and
exposed for various lengths of time to a source of U.V. light
(U.V. Germicidal Sterilamp, G30T8, 30 watt, Westinghouse Electric
Co., NJ) at a distance of 10 cms. Percent activity of the virus
was determined by plaque assay (Figure 2)
.
Growth of Viruses in Lymphocytes . BVD or IBR virus, 1 x 10 PFU/ml
was added to sets of mixed lymphocytes cultures (1 x 10 cells)
in two ml of RPMI, with 10% calf serum, tested free of anti-IBRV
and anti-BVDV, and incubated at 37° C. At 0, 24, 48, 72 and 96
hours, cultures were washed three times with cold PBS and resus-
pended in two ml media. 0.2 ml from each sample was inoculated
on MDBK cells and plaque assayed (Table 1)
.
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Adsorption of H-Cortisol to Bovine Lymphocytes . Table 2 illus-
trates the adsorption of radioactive Cortisol to bovine
lymphocytes. Samples were processed for counting as described
previously at 0, 0.5, 4, 8, 24 and 48 hours of incubation.
Adsorption of H-Hormones to Bovine Lymphocytes . A suspension
of 5 x 10 mixed lymphocytes were added to triplicate tubes con-
taining 0.2 uCi of H-hormone and to 500 ng of the corresponding
non-radioactive hormone. Cultures were placed in C0 2 incubator
for four hours. At the end of incubation, cells were washed
twice with cold PBS and transferred on glass fiber filters in
a sampling manifold and subsequently placed in scintillation
vials for counting (Table 3)
.
Hematological and Serum Profiles of Calves . Tables 4 to 9 show
the hematological and serum profiles of control and vaccinated
calves before and after inoculation of the vaccines.
Figure 1. Formalin inactivation of IBRV and BVDV . IBR and BVD
viruses were treated with formalin at final concen-
trations of 1:1000, 1:2000, 1:4000, 1:8000, 1:16000
and 1:32000. The virus was plaque assayed to deter-
mine the percent activity remaining. Symbols: #
IBRV;
—
O
— BVDV.
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Figure 2. Inactivation of IBRV and BVDV by UV irradiation .
One ml of virus (1 x 10
7 PFU) was U.V. irradiated for
0-5 minutes. The virus was collected and plaque
assayed to determine the percent activity remaining.
Symbols: ©— IBRV; O— BVDV.
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SECTION VI
DETAILED METHODOLOGY AND REAGENTS
TABLE 1
GROWTH OF IBR AND BVD VIRUSES IN BOVINE LYMPHOCYTES
89
P.F.U. Recovered per 0.2 ml
Length of
Culture
(hours)
IBRV BVDV
Original
Sample
lO"1
Dilution
Original
Sample
10" 1
Dilution
Lysis 33 Lysis Lysis
24 95 8 Lysis 75
48 51 6 29 3
72 19 13 1
96
TABLE 2
ADSORPTION OF H-CORTISOL TO BOVINE LYMPHOCYTES
90
Hours of
Incubation DPM
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0.5 352
4 370
8 349
24 330
48 284
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SECTION VI
DETAILED METHODOLOGY AND REAGENTS
Reagents and Addresses
99
Absolute Alcohol
(analytical grade)
Agar
Dimethyl Sulfoxide
Dioxane
DNase (pancreatic)
EDTA
Fetal Calf Serum
Fungizone
Hormones (non-radioactive)
Hormones (tritiated)
Horse Serum
Kanamycin (Kantrex)
Ketamine Hydrochloride
Medium 199
Minimal Essential Media
Napthalene (recrystalized)
Neutral Red
Omnifluor
Penicillin G
Phytohemagglutinin
RPMI-1640
BBL, Cockeysville, MD
Mallinckrodt Chemical Co.,
St. Louis, MO
Scientific Products, IL
Sigma Chemical Co., St. Louis, MO
Mallinckrodt Chemical Co.,
St. Louis, MO
Kansas City Biological Co.,
Kansas City, KS
E. R. Squibb and Sons, NY
Calbiochem, Los Angeles, CA
New England Nuclear, Boston, MA
Kansas City Biological Co.,
Kansas City, KS
Bristol Laboratories, Syracuse, NY
Bristol Laboratories, Syracuse, NY
Grand Island Biological Co.,
Grand Island, NY
Grand Island Biological Co.,
Grand Island, NY
Mallinckrodt Chemical Co.,
St. Louis, MO
Fisher Scientific Co., Fairlawn, NJ
New England Nuclear, Boston MA
E. R. Squibb and Sons, NY
Sigma Chemical Co., St. Louis, MO
Grand Island Biological Co.,
Grand Island, NY
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RNase
Streptomycin Sulfate
Toluene
Trichloroacetic Acid
Tritiated Thymidine
Trypsin
Sigma Chemical Co., St. Louis, MO
Eli Lily, Indianapolis, IN
Mallinckrodt Chemical Co.,
St. Louis, MO
Mallinckrodt Chemical Co.,
St. Louis, MO
New England Nuclear, Boston, MA
Difco, Detroit, MI
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Reagents
Agar : 2% purified agar dissolved in deionized water and autoclaved
for use. A mixture of 50% agar - 50% (2X) MEM is used for
plaquing.
Antibiotics :
Penicillin (1,000,000 units)
Streptomycin (1 g)
Kanamycin (50 mg) is dissolved in 100 ml of sterile deionized
water. One ml of PSK stock solution is added to give a
final concentration of: 100 units penicillin, 1 mg strepto-
mycin and 5 ng kanamycin/ml media.
Dimethyl Sulfoxide (CH3 ) 2S0 4 :
For freezing cells, this is made to an appropriate concen-
tration (10%) and autoclaved 10 minutes at 15 minutes.
DNase : 2 mg/ml, stock. A final concentration of 10 ug/ml is used.
ENase: 2 mg/ml, stock. A final concentration of 10 ug/ml is used.
Fungizone : 50 mg (one vial) plus 20 ml sterile deionized water.
Add 0.2 ml/liter of media.
Hormones :
H-cortisol - specific activity (S.P.) 44.3 Ci/mmol
H-corticosterone (S.P.) 47.5 Ci/mmol
H-progesterone (S.P.) 55.7 Ci/mmol
102
All tritiated hormones diluted in R.P.M.I. to a concentration
of 1 uCi/ml. In adsorption studies, 0.2 ml of this preparation
is used.
Non-radioactive hormones, 25 mg, dissolved in 5 ml of acetone-
alcohol (1:1) mixture to give stock of 5 mg/ml. Diluted in
R.P.M.I. to 5, 50, 500, 5000 ng/ml and used.
Neutral Red : A solution (0.015%) for plaquing is prepared from
powder with deionized water and dissolved in a 37 C
water bath. Whatman #2 filter paper is used for filtration.
Sterilize by autoclaving and store at 4 C, protected from
light. 1.5 ml stock/100 ml agar and media.
Phy-tohemaqglutinin : 50 ug/ml in RPMI 1640 stock. A final concen-
tration of 2.5 ug/ml is used.
Phosphate-Buffered Saline (PBS) :
Solution 1
Solution 2
Buffer Stock
134 g/1 deionized H2
69.1 g/1 deionized HjC
386 ml solution 1
NaH-PO.'H.O 114 ml solution 2
2 4 2
Deionized Water 500 ml
pH 7.15
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PBS:
80 ml buffer stock
17 g NaCl
1920 ml deionized water
pH 7.2
Autoclave at 15 lbs. for 15 minutes
Scintillation Fluid :
360 ml Toluene
360 ml Dioxane
80 g Napthalene
216 ml Absolute alcohol
4 g Omnifluor
Thymidine, tritiated i
Specific activity 43 Ci/nmol
Stock of 10 uCi/ml made in RPMI. For blastogenesis
studies, 0.1 ml of this dilution is used.
Trypsin :
1 g/400 ml trypsin in PBS made and frozen for use.
Working Solution:
20 ml 0.25% trypsin
30 ml PBS
0.5 ml 10% EDTA
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Abstract
Humoral and cell mediated immune response was studied in
twenty-four dairy calves inoculated with a commercial modified
live polyvalent vaccine containing both infectious bovine rhino-
tracheitis virus (IBRV) and bovine virus diarrhea virus (BVDV)
.
Plaque reduction and lymphocyte blastogenesis assays were used
to measure serum antibodies and cellular immunity, respectively.
Serum antibody titers of 1/80 and 1/160 were observed in these
animals against IBRV and BVDV, respectively. However, cell
mediated immune response was not detected as demonstrated by-
lack of incorporation of
3H-thymidine ( 3H-TdR) in lymphocyte
cultures of these calves in the presence of specific virus
antigens.
Post vaccinal reactions due to modified live viruses have
been reported by many investigators. Cell mediated immune
response to inactivated vaccines against IBR and EVD viruses
have not been illucidated. A prototype study in calves vac-
cinated with inactivated-adjuvated vaccines was undertaken.
The vaccines were prepared by inactivating IBR or BVD virus
with formalin (1:1000) and homogenizing with Freund's incom-
plete adjuvant. Each vaccine was inoculated into a calf. Two
other calves were vaccinated each with a modified live IBR
virus intranasally or modified live BVDV intramuscularly.
Humoral response was elicited earlier in calves given inacti-
vated virus vaccines as compared to those vaccinated with
modified live virus (MLV) vaccines. Serum antibody titers of
1/160 and 1/80 for IBRV and BVDV, respectively, were observed
one week post vaccination, reaching maximum titers of 1/640 and
1/1280 by six to nine weeks. In addition, cell mediated immune
response was detected in the calf vaccinated with formalized
adjuvated IBRV, as demonstrated by lymphocyte blastogenesis
studies. The mean stimulation index, as measured by the ratio
of radioactive thymidine counts of cells stimulated by antigen
to that of cells without antigen, was 11.5 during the course of
study. All other calves did not show any appreciable rise in
stimulation indices, as indicated by lack of response and failure
of incorporation of H-TdR when their lymphocytes were stimulated
with specific virus antigens.
The role of steroid hormones in the immune response to bovine
respiratory disease viruses has not been thoroughly investigated.
Corticosteroid levels in calves have been shown to increase
during times of stress in feedlots or during transportation.
The interaction of IBR or BVD virus with lymphocytes in the
presence of Cortisol was studied. Radioactively labelled IBRV
and BVDV were prepared by growing them in Madin Darby bovine
3 3kidney cells supplemented with H-thymidine or H-uridme,
respectively. The viruses were treated with DNase or RNase,
ultracentrifuged at 200,000 g and resuspended in culture medium.
The specificity of receptors for Cortisol on bovine lympho-
cytes from immune and control calves was demonstrated by
decreased uptake of H-cortisol in the presence of the competing
non-radioactive hormone. Increasing concentrations of Cortisol
failed to influence the degree of adsorption of labelled IBRV
or BVDV on lymphocytes from control and vaccinated calves as
indicated by recovery of similar number of radioactive counts
and plaque forming units. This indicated the presence of dif-
ferent receptors on bovine lymphocytes for Cortisol and the
viruses.
Physiological concentrations of Cortisol in cultures of
lymphocytes from the calf vaccinated with inactivated IBRV
inhibited the stimulation by specific virus antigen suggesting
depression of cell mediated immune response in the presence of
the hormone.
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